Day One Biopharmaceuticals
DAWN46
$7.90arrow_drop_up5.91%$0.43
DAWN46
$7.90
arrow_drop_up5.91%| Key Stats | |
|---|---|
| Open | $7.41 |
| Prev. Close | $7.44 |
| EPS | -1.02 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 7.32 | 7.90 |
| 52 Week Range | 6.53 | 18.07 |
| Ratios | |
|---|---|
| EPS | -1.02 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.87% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
DAWN-
US Healthcare Sector-
US Market-
check_circle
DAWN / Market
DAWN exceeded the US Market which returned 1.29% over the last twenty four hours.check_circle
DAWN / Healthcare Sector
DAWN exceeded the US Healthcare sector which returned 3.64% over the last twenty four hours.Day One Biopharmaceuticals (DAWN) Statistics
Keep an eye on Day One Biopharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Day One Biopharmaceuticals (DAWN) stock's performance compared to its sector and the market over the past year?
Over the past year, Day One Biopharmaceuticals (DAWN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.41%, Day One Biopharmaceuticals has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 35.60%, it has fallen short of the market average. This comparison highlights Day One Biopharmaceuticals's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Day One Biopharmaceuticals (DAWN) stock?
The PE ratio for Day One Biopharmaceuticals (DAWN) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Day One Biopharmaceuticals (DAWN) stock?
The Earnings Per Share (EPS) for Day One Biopharmaceuticals (DAWN), calculated on a diluted basis, is -$1.02. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Day One Biopharmaceuticals (DAWN) stock?
The operating margin for Day One Biopharmaceuticals (DAWN) is -223.68%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Day One Biopharmaceuticals (DAWN) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Day One Biopharmaceuticals (DAWN) is -$210.71M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Day One Biopharmaceuticals (DAWN) have?
Day One Biopharmaceuticals (DAWN) has a total debt of $2.6M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$122.37M.